Message from the C-Suite | Future Frontiers in Biomedical Innovation for Healthy Aging



November 9, 2022


Deloitte Consulting

13:20 GMT | 14:20 CET | 8:20am EST

Healthy aging will be spurred by future innovation tackling chronic disease and managing multiple co-morbidities that rise in prevalence with age. Bayer’s Head of Pharmaceuticals will describe some of the most exciting biomedical advancements on the horizon.


Stefan Oelrich (video message)
Member, Board of Management of Bayer AG, and Head, Pharmaceuticals Division
Back to Agenda